Pluribus Labs’s CVS Health CVS Stock Holding History

Pluribus Labs’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$231K	Buy	+2,492	New	+$243K	0.42%	81

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pluribus Labs's CVS Position: Q2 2022 in Review

Pluribus Labs opened a new position in CVS Health (CVS) in Q2 2022: 2,492 shares worth $231K. The stake represents 0.42% of the portfolio and ranks #81 among its holdings.

2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

Pluribus Labs held 2,492 shares of CVS Health worth $231K as of Q2 2022.
CVS Health was a new Pluribus Labs position in Q2 2022.
CVS Health made up 0.42% of Pluribus Labs's portfolio in Q2 2022, its #81 holding.
2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.